Trending: Merck's Molnupiravir Approved for Emergency Use in China
December 30 2022 - 12:39PM
Dow Jones News
13:09 -- Merck & Co. Inc. is one of the most talked about
companies in the U.S. across all news items in the last 12 hours,
according to Factiva data. Regulators in China said the company's
Molnupiravir has been approved for emergency use. Molnupiravir is
used as a treatment for patients with Covid-19. Dow Jones & Co.
owns Factiva. (stephen.nakrosis@wsj.com)
(END) Dow Jones Newswires
December 30, 2022 13:24 ET (18:24 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2024 to May 2024
Merck (NYSE:MRK)
Historical Stock Chart
From May 2023 to May 2024